Kausikh Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 1.34 Cr
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 46.19 Cr
- Satisfied Charges ₹ 7.83 Cr
- Revenue Growth -11.31%
- Profit Growth -67.61%
- Ebitda -27.55%
- Net Worth 7.39%
- Total Assets -7.91%
About Kausikh Therapeutics
Kausikh Therapeutics Private Limited (KTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 April 2000 and has a history of 24 years and ten months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.34 Cr.
The company currently has active open charges totaling ₹46.19 Cr. The company has closed loans amounting to ₹7.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vaidhyanathen Neelakantan, Vaidhyanathan Ramasubrahmanian, and Anantharamkrishnan Vaidhyanathen serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232TN2000PTC044776
- Company No.
044776
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Kausikh Therapeutics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaidhyanathen Neelakantan  | Managing Director | 19-Apr-2000 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaidhyanathan Ramasubrahmanian | Director | 19-Apr-2000 | Current |
| Anantharamkrishnan Vaidhyanathen | Director | 19-Apr-2000 | Current |
Financial Performance of Kausikh Therapeutics.
Kausikh Therapeutics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.31% decrease. The company also saw a substantial fall in profitability, with a 67.61% decrease in profit. The company's net worth moved up by a moderate rise of 7.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kausikh Therapeutics?
In 2023, Kausikh Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Om Charity India FoundationVaidhyanathan Ramasubrahmanian is a mutual person
Globexims Health Care Private LimitedVaidhyanathen Neelakantan is a mutual person
- Tathastu Exim Private Limited
Vaidhyanathen Neelakantan is a mutual person
Charges (Loans)
₹46.19 Cr
₹7.83 Cr
Charges Breakdown by Lending Institutions
- Others : 46.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Feb 2020 | Others | ₹30.19 Cr | Open |
| 26 Apr 2019 | Others | ₹16.00 Cr | Open |
| 03 Feb 2014 | Indian Bank | ₹9.00 M | Satisfied |
| 25 Mar 2010 | Indian Bank | ₹3.93 Cr | Satisfied |
| 13 Sep 2007 | Hdfc Bank Limited | ₹0.22 M | Satisfied |
How Many Employees Work at Kausikh Therapeutics?
Kausikh Therapeutics has a workforce of 176 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kausikh Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kausikh Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
